Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 21 July 2009
[DOI: 10.1126/scisignal.2000308]

Supplementary Materials for:

Inhibition of mTOR Signaling in Parkinson's Disease Prevents L-DOPA–Induced Dyskinesia

Emanuela Santini, Myriam Heiman, Paul Greengard, Emmanuel Valjent, Gilberto Fisone*

*To whom correspondence should be addressed. E-mail: gilberto.fisone{at}ki.se

This PDF file includes:

  • Fig. S1. Rapamycin does not affect L-DOPA–induced phosphorylation of GluR1 and ERK2.
  • Fig. S2. Rapamycin does not affect L-DOPA–induced phosphorylation of Lys14-acetylated histone H3.
  • Fig. S3. Evaluation of the degree of DA denervation after striatal 6-OHDA injection.
  • Table S1. Effect of 6-OHDA and L-DOPA on selected proteins involved in mTOR signaling.

[Download PDF]

Technical Details

Format: Adobe Acrobat PDF

Size: 718 KB


Citation: E. Santini, M. Heiman, P. Greengard, E. Valjent, G. Fisone, Inhibition of mTOR signaling in Parkinson’s disease prevents L-DOPA–induced dyskinesia. Sci. Signal. 2, ra36 (2009).

© 2009 American Association for the Advancement of Science


To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882